Company Statements

Biocon Biologics  /  Company Statements

Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru

  • Posted by: Biocon Biologics

Biocon Biologics issues a statement in response to the media reports related to bribery allegations

  • Posted by: Biocon Biologics

Biocon Biologics Denies Bribery Allegations

  • Posted by: Biocon Biologics

The USFDA issues a complete response letter for the Biologics License Application (BLA) for insulin Aspart

  • Posted by: Biocon Biologics

Biocon Biologics Insulin Manufacturing Facility in Malaysia Completes U.S. FDA (PAI) Inspection

  • Posted by: Biocon Biologics

Kiran Mazumdar-Shaw Joins Board of Trustees of Memorial Sloan Kettering Cancer Center, U.S.

  • Posted by: Biocon Biologics

Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevacizumab

Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevacizumab
  • Posted by: Biocon Biologics

Biocon Biologics and Viatris Receive European Commission Approval for Kixelle, Biosimilar Insulin Aspart

  • Posted by: Biocon Biologics

Biocon Biologics and Viatris Receive European Commission Approval for Kixelle, Biosimilar Insulin Aspart

  • Posted by: Biocon Biologics

Biocon Biologics Statement on the Status of Bevacizumab FDA Action Date in Dec 2020

  • Posted by: Biocon Biologics
Share
buy twitter followers - sahadan tv - buy facebook followers -

çekişmeli boşanma avukatı

- volgers kopen - Antalya vip transfer - funbahis - tümbet - betosfer giriş